2012
DOI: 10.1016/j.bmcl.2012.04.024
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of XL413, a potent and selective CDC7 inhibitor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
81
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 80 publications
(86 citation statements)
references
References 19 publications
5
81
0
Order By: Relevance
“…The phosphorylation of Mcm2 on S40 and S53 has been exploited as a readout for Cdc7 kinase activity and has been used in screens for the development of small-molecule inhibitors of Cdc7 (Montagnoli et al., 2008, Koltun et al., 2012). We used  Xenopus egg extracts to evaluate the hyper-phosphorylation of Mcm4 and the phosphorylation of Mcm2 at the Xenopus orthologous S40 and S53 residues (S25 and S38, respectively) as readouts for the DDK activity required for DNA replication (Figure 1A).…”
Section: Resultsmentioning
confidence: 99%
“…The phosphorylation of Mcm2 on S40 and S53 has been exploited as a readout for Cdc7 kinase activity and has been used in screens for the development of small-molecule inhibitors of Cdc7 (Montagnoli et al., 2008, Koltun et al., 2012). We used  Xenopus egg extracts to evaluate the hyper-phosphorylation of Mcm4 and the phosphorylation of Mcm2 at the Xenopus orthologous S40 and S53 residues (S25 and S38, respectively) as readouts for the DDK activity required for DNA replication (Figure 1A).…”
Section: Resultsmentioning
confidence: 99%
“…The defects in mitosis observed after 24-hour treatment with 1µM DDKi (PHA) were not a by-product of apoptosis as the same effect was seen both with and without co-treatment with the pan-caspase inhibitor zVAD. To confirm that this effect is DDK-specific we also tested the more selective biochemical DDK inhibitor, XL413 [45]. In HCC1954 cells and many other cell lines, XL413 is a poor in vivo inhibitor of DDK activity and has little effect on cell growth even at high inhibitor concentrations [18].…”
Section: Low Dose Ddki Causes Aberrant Mitotic Structuresmentioning
confidence: 99%
“…5D), was synthesized, tested for inhibition of human Cdc7 in vitro and in vivo, and advanced into clinical trials as a potential chemotherapeutic agent (42). To determine whether Drosophila Cdc7 is relevant as a model for human Cdc7 function, we tested whether XL413 could inhibit the kinase activity of Drosophila Cdc7 in vitro.…”
Section: Drosophila Contains Two Cdc7mentioning
confidence: 99%
“…BLU502A250UC), substrate (0.5 g of Mcm4-GST or Mcm2-GST or 2 g of purified HeLa core histones), and Cdc7 (6, 12, or 24 ng) or DDK (6, 12, 24 ng Cdc7 with co-purified ChiffonN) were incubated at 30°C for 30 min (Mcm2/4 as substrate) or 60 min (core histones as substrate). The XL413 inhibitor was synthesized by us as described previously (42) and solubilized in DMSO. Reaction mixtures were separated by SDS-PAGE (10% gel, Mcm2/4; 15% gel, HeLa core histones), stained with Coomassie, imaged, dried, and exposed to a phosphor screen (GE Healthcare).…”
Section: Cloning and Purification Of Mcm2-gst And Mcm4-gst-mentioning
confidence: 99%